Levels of evidence in canine oncology trials-a case in point

Veterinary and Comparative Oncology

Volumn 11, Issue 3, 2013, Pages 167-168

  Vail, David M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

ANIMAL; ANIMAL DISEASE; CLINICAL TRIAL (TOPIC); DOG; DOG DISEASE; EDITORIAL; MELANOMA; MOUTH TUMOR; RETROSPECTIVE STUDY; STANDARD;

ANIMALS; CANCER VACCINES; CLINICAL TRIALS AS TOPIC; DOG DISEASES; DOGS; MELANOMA; MOUTH NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84881319204     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/vco.12058     Document Type: Editorial

References (5)

1. Ottnod JM, Smedley RC, Walshaw R, Hauptman JG, Kiupel M, Obradovich JE. A retrospective analysis of the efficacy of oncept vaccine for the adjunct treatment of canine oral malignant melanoma. Veterinary and Comparative Oncology 2013; 11: 219-229.
2. Grosenbaugh DA, Leard AT, Bergman PJ, Klein MK, Maleo K, Susaneck S, Hess PR, Jankowski MK, Jones PD, Leibman NF, Johnson MH, Kurzman ID and Wolchok JD. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor. American Journal of Veterinary Research 2011; 72: 1631-1638.
3. US FDA Guidance for Industry. E10 choice of control group and related issues in clinical trials document. May, 2009. Available at: http://www.fda.gov/RegulatoryInformation/Guidances/ucm125802.htm [accessed 17 June 2013].
4. US FDA Guidance for Industry. Clinical trial endpoints for the approval of cancer drugs and biologics. May, 2007. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071590 [accessed 17 June 2013].
5. US FDA. Conditional approval of animal drugs-what does this mean for veterinarians? May, 2013. Available at: http://www.fda.gov/AnimalVeterinary/NewsEvents/FDAVeterinarianNewsletter/ucm252075.htm [accessed 17 June 2013].